We are live on ! Find out more

Invesco NASDAQ Biotechnology ETF

IBBQ

Market cap $96.8M

34.81 USD

-0.59

1.67%

At close Updated Sep 23, 11:07 AM EDT

1 day

-1.67%

5 days

-0.37%

1 month

-3.6%

3 months

13.09%

6 months

24.5%

Year to date

22.66%

1 year

45.41%

5 years

28.21%

10 years

36.08%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 33.3%

Neutral 44.4%

Negative 22.2%

The Motley Fool

Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH

The Invesco Nasdaq Biotechnology ETF carries a lower expense ratio and delivered higher total returns over the trailing 12 months than the iShares U.S. Healthcare ETF. The iShares U.S. Healthcare ETF provides broader industry diversification across the medical sector, while the Invesco Nasdaq Biotechnology ETF focuses strictly on biotechnology and pharmaceuticals.

Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH

The Motley Fool

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

The Fidelity MSCI Health Care Index ETF features a lower expense ratio of 0.08% and a higher dividend yield of 1.2%. The Invesco Nasdaq Biotechnology ETF has delivered a higher 1-year total return of 56.4% but carries a more significant maximum drawdown of 37.9%.

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

The Motley Fool

IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?

The Invesco Nasdaq Biotechnology ETF (IBBQ) offers a much broader portfolio compared to the concentrated approach of the Invesco Biotechnology & Genome ETF (PBE). IBBQ charges a significantly lower expense ratio than PBE.

IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?

The Motley Fool

Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ?

Invesco Nasdaq Biotechnology ETF has a lower expense ratio but higher price volatility than Invesco S&P 500 Equal Weight Health Care ETF. Invesco S&P 500 Equal Weight Health Care ETF holds fewer stocks but uses an equal-weighting strategy to diversify across the large-cap healthcare sector.

Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ?

The Motley Fool

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

The Health Care Select Sector SPDR Fund (XLV) carries a lower expense ratio and a higher dividend yield than the Invesco Nasdaq Biotechnology ETF (IBBQ). IBBQ has significantly outperformed on a one-year basis, but has also experienced a much more severe five-year maximum drawdown.

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

The Motley Fool

Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ

The Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield compared to the Invesco Nasdaq Biotechnology ETF. The Invesco Nasdaq Biotechnology ETF has outperformed on 1-year total returns but carries a significantly deeper maximum drawdown.

Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ

The Motley Fool

IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?

The Invesco Nasdaq Biotechnology ETF (IBBQ) carries a lower expense ratio than the iShares Global Healthcare ETF (IXJ). IXJ offers broad global exposure across the healthcare sector, while IBBQ is concentrated exclusively in Nasdaq-listed biotechnology and pharmaceutical companies.

IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?

The Motley Fool

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

State Street Health Care Select Sector SPDR ETF offers a lower expense ratio and a higher dividend yield than Invesco Nasdaq Biotechnology ETF Invesco Nasdaq Biotechnology ETF provides concentrated exposure to the biotech industry but has experienced higher volatility and a deeper maximum drawdown State Street Health Care Select Sector SPDR ETF tracks a broader index of 60 healthcare stocks from the S&P 500 compared to the Invesco fund's 253 biotech holdings

Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?

The Motley Fool

Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?

Invesco Nasdaq Biotechnology ETF offers a lower expense ratio and a higher trailing dividend yield than State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF has delivered a higher 1-year total return and experienced a less severe maximum drawdown than Invesco Nasdaq Biotechnology ETF.

Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Medical Technology Stocks: Innovation Endures As Valuations Reset

See News Rankings

Price charts implemented using Lightweight Charts™